Subject(s)
Anthralin/therapeutic use , Psoriasis/drug therapy , Administration, Cutaneous , Adolescent , Adult , Aged , Aged, 80 and over , Ambulatory Care , Child , Humans , Middle Aged , Multicenter Studies as Topic , OintmentsABSTRACT
Therapeutic plasmapheresis was successfully used in a 29-year-old man with corticosteroid-resistant pemphigus vulgaris who had severe side-effects from the medication. 4 plasmaphereses were performed over a period of 3 weeks with removal of a total of 7900 ml of plasma. Concurrently he received large doses of adrenal steroids and Imuran. There was clinical improvement soon after the first plasmapheresis and 8 weeks after the treatment was started he was free of lesions. IC-Ab titers markedly decreased during the course of treatment and continued to decrease after it was completed. Side-effects were few and relatively mild. Plasmapheresis may be a useful adjunct in the treatment of pemphigus vulgaris resistant to conventional therapy. It may be used initially together with corticosteroids, giving more rapid improvement, as well as a corticosteroid-sparing effect.
Subject(s)
Pemphigus/therapy , Plasmapheresis , Adrenal Cortex Hormones/therapeutic use , Adult , Azathioprine/therapeutic use , Combined Modality Therapy , Humans , Male , Pemphigus/pathologyABSTRACT
A description of New York State's program for providing assistance to patients on home dialysis. This program, which antedates the Medicare benefits provided under P.L. 92-603, Section 299I, was designated a Medicare provider in September 1975. Through its program, the Institute is able to provide home dialysis patients in the State with equipment, supplies and medications at a savings to the payors of these services, and presents a viable alternative to in-center dialysis.
